- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Medicare moves to pay for stroke thrombolytic therapy
Hospitals will no longer lose money for thrombolizing stroke patients with tissue plasminogen activator (tPA).
Hospitals will no longer lose money for thrombolizing stroke patients with tissue plasminogen activator (tPA).
In midsummer, the Centers for Medicare and Medicaid Services unveiled DRG 559, a new code that pays $11,578 per case of acute ischemic stroke treated with a thrombolytic. Hospitals had previously been paid a flat rate of about $4000 to $6000 per case, regardless of whether thrombolytics were used.
"We have been barely breaking even for some time here," said Dr. Kieran Murphy, director of interventional neuroradiology at Johns Hopkins University. "Even though we have an excellent program in place that allows us to treat these patients appropriately, we've had to be very cautious, trying to lose as little money as possible."
New Literature Review Assesses Merits of Cardiac MRI After Survival of Sudden Cardiac Arrest
April 19th 2024While noting inconsistencies with the diagnostic yield of cardiac MRI in patients who survived sudden cardiac arrest, researchers cited unique advantages in characterizing ischemic cardiomyopathy (ICM) and facilitating alternate diagnoses.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
